From: miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6
Characteristics | n | miR-454 expression | P-value |
---|---|---|---|
Age | Â | Â | Â |
 < 59 | 7 | 6.41 ± 5.33 | 0.69 |
 ≥ 59 | 6 | 8.37 ± 11.39 |  |
Clinical stage | Â | Â | Â |
 I–II | 7 | 12.13 ± 8.92 | 0.016* |
 III–IV | 6 | 1.70 ± 0.77 |  |
Lymph node metastasis | Â | Â | Â |
 Yes | 7 | 5.69 ± 10.59 | 0.47 |
 No | 6 | 9.21 ± 4.88 |  |